Delpharm secures corticoids manufacturing in France.

Published on

To address stock shortages of prednisolone and prednisone-based medicines, Delpharm has increased its capacity by acquiring a new, fully automated, high-speed packaging line at its Lille site.

Delpharm Lille has increased its corticoid production capacity significantly, from 8 to 20 million boxes a year.

Download the press release for more information

Delpharm press release PDF - 128.8 KiB